Objective: To review the literature on portal vein thrombosis in children and adolescents, focusing on its diagnosis, complications and treatment.
Introduction
Extrahepatic portal vein obstruction (EHPVO) is an important cause of portal hypertension (PH) among children. It is characterized mainly by portal vein thrombosis (PVT), and is detected in 40% of children with upper gastrointestinal bleeding (UGIB) caused by esophageal varices. It may be asymptomatic. However, the mortality and morbidity rates are high, due to UGIB. Approximately 79% of children diagnosed with PVT will have at least one episode of UGIB in their lifetime. 1 The present article aims to build up the profile of children with PVT, to investigate the predisposing factors, complications, and therapeutic approach, by reviewing the medical literature.
Anatomy and embryology
The liver originates from the anterior primitive intestine, and its primordial form pars hepatis develops as a duodenal diverticulum in the fourth gestational week. Its full development occurs in the third month. Fetal hepatic blood flow comes from the hepatic artery and from the portal and umbilical veins, which form the portal sinus. At birth, this flow corresponds to nearly 5% of an infants total body weight, whereas, in an adult, it does not exceed 2.5%. The liver is responsible for hematopoiesis during the fetal period. In the seventh gestational week, hematopoietic cells outnumber functional hepatocytes.
After the second month of life, the liver no longer produces red blood cells. 2 The liver can be divided into two large lobes (right and left), in additional to the caudate and quadrate lobes, which are small. On top of that, there is a functional subdivision, based on blood supply, which divides the liver into eight segments. Hepatic architecture is extremely complex. The basic functions of the liver are carried out by hepatocytes. 3 The liver has a dual blood supply via the hepatic artery and portal vein. The portal vein carries venous blood from the digestive tract into hepatic sinusoids, which is drained by the hepatic veins into the inferior vena cava. The portal vein is formed by the confluence of the paraumbilical and subcutaneous veins.
Portal hypertension
Portal vein is responsible for around two thirds of the blood flow into the liver. It supplies blood that is rich in oxygen, nutrients, growth factors, hormones, among other elements. Although the liver receives a large amount of blood (approximately 25% of the cardiac output per minute), the portal vein only withstands low pressures. PH occurs when portal vein pressure exceeds 10 mmHg. 5, 6 Doppler ultrasonography shows a continuous blood flow, with a normal range from 15 to 30 cm/s. 7 An increase in portal pressure results from the oscillation of intravascular pressure (hyperdynamic state) and from the elevated resistance to this flow. Thus, oscillation of pressure within blood vessels is directly proportional to the flow within the portal system and to the resistance to this flow (Ohms law). In turn, resistance to blood flow is inversely proportional to the fourth power of the radius of the vessel (Poiseuilles law). 2, 3, 6 Based on these physical laws, one may conclude that small variations in portal vessels cause large increases in pressure.
PH can be extrahepatic (prehepatic obstruction), intrahepatic or post-sinusoidal (Table 1) . Another classification takes into account the etiology of PH:
cirrhotic and noncirrhotic. 8 The consequences of PH are related to the interactions produced by the development of portal systemic collaterals, which cause UGIB. 12 The causes of PVT can be split into four different groups: direct injury to the portal vein and consequent thrombus formation and obstruction, as occurs in omphalitis or in umbilical catheterization; congenital malformation of the vascular system with involvement of the portal system associated with other cardiovascular disorders; indirect factors that predispose to thrombus formation in the portal system; idiopathic PVT, i.e., the etiology cannot be identified. 9,11-13 Table 2 lists the main causes of PVT.
subdiaphragmatic or peripheral), trauma on catheter insertion, and type of solutions infused. 8 In adults, the main cause of thrombosis is thrombophilia secondary to malignant neoplasms. Janssen et al. 14 assessed 172 patients, aged between 14 and 91 years, in a cohort study. They found that 84% had at least one risk factor for EHPVO, such as malignant hepatobiliary diseases, inflammatory abdominal diseases, intra-abdominal surgeries, hypercoagulable states, and myeloproliferative syndrome.
A different category includes cirrhosis-related PVT. In this case, PVT seems to be associated with the low venous blood flow secondary to the increase in intrahepatic resistance, presence of portal lymphangitis, and fibrosis.
About 10% of children with biliary atresia also have PVT. 6 The prevalence of PVT in adults with cirrhosis ranges between 0.6 and 17%. 15, 16 Clinical manifestations
PVT patients initially present with UGIB or splenomegaly on routine clinical examination in asymptomatic individuals.
The initial presence of hematemesis is usually dramatic in a previously healthy child, with past history of morbidity, often without remarkable intercurrent events. Melena may also be observed, but it is less common than Several congenital abnormalities associated with PVT have been described, such as malformations of the heart, of large vessels, of the biliary tract, and of the renal system. 1 Transient ascites may develop after episodes of UGIB.
However, patients with long-established PH secondary to PVT may have ascites without any predisposing factors.
This same group of patients may have low albumin levels, Portal vein thrombosis in children and adolescents Schettino GCM et al.
Sarin & Agarwal 11 compared seven studies that assessed the etiology of portal vein obstruction in infants and children (Table 3) . In most cases, the cause could not be identified and, when it could be, the majority of cases showed direct injury to the umbilical vascular system (omphalitis and umbilical venous catheterization), or intra-abdominal or umbilical sepsis.
However, there seems to be a relationship between the various causes, suggesting the coexistence of a prethrombotic state. 11 With regard to umbilical catheterization, the predisposing factors are: later insertion, catheter dwell time over three days, catheter misplacement (either Another hypothesis is that the low supply of blood to the liver due to the formation of systemic collaterals in PVT patients may cause hepatotrophic hormone deprivation, thus interfering with the childs global growth. 11, 20, 21 Mehrota et al. 22 Therefore, according to the extension of the injury found on ERCP, it is possible to classify portal biliopathy into three types, of which type I is the mildest, as shown in Table 5 .
Coagulation disorders
Protein C deficiency, an endogenous tissue factor pathway inhibitor, is common among children and adolescents with PVT, but it does not seem to have a genetic etiology or to be the main cause of thrombosis. 
Immunity
Patients may have normal humoral immunity. However, some will show abnormal cell-mediated immunity due to the sequestration of T lymphocytes by the spleen.
Nevertheless, manifestations related to immunological disorders are rare among children. 11 
Rectal and esophagogastric varices
The main clinical manifestation of PVT at diagnosis is variceal bleeding. Nearly 90 to 95% of PVT patients have esophageal varices, and 35 to 40% have gastric varices.
The frequency of hypertensive gastropathy, which is lower in PVT patients than in cirrhotic ones, seems to be related to the severity of liver disease. 11, 26 Mortality from gastrointestinal bleeding secondary to variceal rupture amounts to approximately 2 to 5% in PVT patients. 14, 18 Anorectal varices are found in 80 to 90% of patients with portal vein obstruction. They usually are of grade III (larger than 6 mm and protruding into the intestinal lumen). They rarely bleed, but when they do, they cause severe complications. All children with hemorrhoids should be investigated as to the probability of PH. In newborns submitted to umbilical vein catheterization or children with some trauma or intra-abdominal injury that predisposes to portal vein thrombosis, the first step is to determine the level of involvement of the blood vessel, so that the best therapeutic approach can be chosen.
If the child does not show any symptoms of intestinal ischemia, the following procedures should be performed: 
Gastrointestinal bleeding and esophagogastric varices
The approach to UGIB includes the following: 1) primary prophylaxis (patient at a high risk for UGIB, but who has never had bleeding episodes); 2) management of acute bleeding and; 3) secondary prophylaxis (to eliminate varices in patients with history of UGIB).
The use of drug therapy or endoscopy in children with esophageal varices before the first bleeding episode is controversial and there is no consensus about it in the medical literature. 6 In adults with cirrhosis and large varices, beta blockers reduce the risk of bleeding and seem to reduce the mortality associated with UGIB. [30] [31] [32] This type of treatment is already established for this age group. Esophageal variceal band ligation (EVBL) has proved efficient as primary prophylaxis in adults, whereas the use of sclerotherapy has been discontinued due to the high incidence of complications. 33, 34 The current trend consists of the use of primary prophylaxis in pediatric patients, even though there is a paucity of studies involving children. 26, 35 Due to the risks of any extensive bleeding, patients with upper gastrointestinal bleeding should be immediately sent to a referral hospital for a more adequate approach. and portosystemic shunts. 18 Beta blockers are the only pharmacological agents with proven efficacy in reducing the risk of recurrent bleeding in adults. Studies involving children are scarce. 37, 38 The dose should be gradually increased until 25% of the baseline heart rate at rest is reached. In children, the initial dose usually corresponds to 1 mg/kg/ day. 38 rebleeding and with fewer complications. 36, 40 It is recommended that an annual endoscopic followup be performed during the first 4 years after variceal eradication, due to the risk of rebleeding. 41 Patients should be advised not to take ASA.
Surgical treatment
There has been a consensus agreement on the conservative treatment of patients with extrahepatic PH, thus avoiding surgical interventions. However, the following aspects should be taken into consideration: risk of death in which endoscopic treatment does not yield good results. 45 An alternative is the use of Rex shunting, a type of portosystemic shunt with a left mesenteric portal bypass that restores blood flow to the liver, supplying it with hepatotrophic substances and other nutrients. 43 Orloff observed. 42 Children with scheduled splenectomy must be immunized with pneumococcal vaccine before surgery. 44 Some surgical complications, which result from the invasive procedure, include:
1) Central venous catheter infection, sepsis, atelectasis, among others, in the immediate postoperative period.
2) Recurrent variceal bleeding due to stenosis at the anastomosis or venous thrombosis, hepatic encephalopathy, intestinal obstruction, in the late postoperative period.
Despite the lower risk of encephalopathy inherent to the shunting procedure, PVT patients are at a greater risk for stenosis or thrombosis at the surgical anastomosis.
Portal biliopathy
Depending on where gallstones are located or on the site of stenosis, the clinical manifestation will determine the surgical approach that should be used. If cholangitis or cholelithiasis is present, cholecystectomy, biliary stenting or endoscopic sphincterotomy is recommended. If the patient is asymptomatic, portosystemic shunting should be scheduled in order to prevent future complications that may arise from the progression of biliopathy. 17, 24 Growth deficit
There is a paucity of studies on the growth and development of children with EHPVO secondary to PVT. 
